SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000885590-15-000032
Filing Date
2015-04-30
Accepted
2015-04-30 15:37:01
Documents
13
Period of Report
2015-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q valeantq12015.htm 10-Q 1576034
2 EXHIBIT 10.5 ex105.htm EX-10.5 223855
3 EXHIBIT 10.6 ex106.htm EX-10.6 234711
4 EXHIBIT 31.1 exhibit311.htm EX-31.1 14530
5 EXHIBIT 31.2 exhibit312.htm EX-31.2 14154
6 EXHIBIT 32.1 exhibit321.htm EX-32.1 8789
7 EXHIBIT 32.2 exhibit322.htm EX-32.2 8241
  Complete submission text file 0000885590-15-000032.txt   14455613

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT vrx-20150331.xml EX-101.INS 2543308
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrx-20150331.xsd EX-101.SCH 60195
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrx-20150331_cal.xml EX-101.CAL 105481
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrx-20150331_lab.xml EX-101.LAB 852590
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrx-20150331_pre.xml EX-101.PRE 510713
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrx-20150331_def.xml EX-101.DEF 354915
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Valeant Pharmaceuticals International, Inc. (Filer) CIK: 0000885590 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-14956 | Film No.: 15818050
SIC: 2834 Pharmaceutical Preparations